Atlas Trials

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Clinical trial NCT00003304 · COMPLETED

Trial details

NCT number
NCT00003304
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain and Central Nervous System Tumors
Start date
1998-04-01
Primary completion
2000-03-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.